using new 3d and fly through tools to visualise contamination...using new 3d and fly through tools...
TRANSCRIPT
![Page 1: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/1.jpg)
Using new 3D and fly through tools to visualise contamination risksPresented by Mairead Kennedy
4 July, 2016
![Page 2: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/2.jpg)
Slide 2 © PharmOut 2015
Case Study - Client brief
Modify and upgrade a pharmaceutical compounding facility and apply for a TGA manufacturing licence.
Provide a risk assessment on potential facility layouts that will accommodate the compounding of both cytotoxic and antibiotic products within the facility
Prepare a facility User Requirements Specification
Prepare a proposed HVAC schematic
Prepare a formal set of layouts, showing material and personnel flows
![Page 3: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/3.jpg)
Slide 3 © PharmOut 2015
Plan View
![Page 4: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/4.jpg)
Slide 4 © PharmOut 2015
3D
![Page 5: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/5.jpg)
Slide 5 © PharmOut 2015
Fly Through
![Page 6: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/6.jpg)
Slide 6 © PharmOut 2015
Cross Contamination Regulations
Operations on differentproducts should not be carriedout simultaneously or consecutively in the same roomunless there is no risk of mix-upor cross contamination.
Eudralex Volume 4, Chapter 5 - 5.9
![Page 7: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/7.jpg)
Slide 7 © PharmOut 2015
ISPE Baseline Guide Vol 4 Logic Diagram
![Page 8: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/8.jpg)
Slide 8 © PharmOut 2015
Routes for Cross-Contamination
Mix Up
Retention
Mechanical Transfer
Airborne Transfer
ISPE Baseline Guide Vol. 7 – Risk Based Manufacture of
Pharmaceutical Products, Section 6.3
![Page 9: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/9.jpg)
Slide 9 © PharmOut 2015
Facility Design
Mix Up
“The contamination at unsafe levels of one product with another via inadequate plant and process design or human error.”
• Most commonly occurs through labelling, receipting, line clearance type problems – human error
How do we prevent mix-up through facility design?
• Considerate design
• Eg. Line clearance, mentalstimulation
• Physical segregation
• even in multi-product facilities
!
?
![Page 10: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/10.jpg)
Slide 10 © PharmOut 2015
Mix Up Prevention
![Page 11: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/11.jpg)
Slide 11 © PharmOut 2015
Facility Design
![Page 12: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/12.jpg)
Slide 12 © PharmOut 2015
Facility Design
Retention
“Carryover of material on product contact surfaces from one productto another in the same equipment used in a sequential or campaignmanner; the residue or accumulated product on product contactsurfaces”
• Most commonly caused by inadequate cleaning
How do we prevent retention ?
• Cleaning process development
!
?
![Page 13: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/13.jpg)
Slide 13 © PharmOut 2015
Facility Design
Mechanical Transfer
“includes all routes by which material can be transferred from contaminated non-product surfaces into the product”
• PPE is a common source of mechanical transfer
Factors which affect the risk are those that influence:
• Transfer of material to a surface
• Association of the surface withthe product at risk
• Release of material from the contaminated surface to theproduct
!
?
![Page 14: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/14.jpg)
Slide 14 © PharmOut 2015
Case Study – Multi Product Facility
![Page 15: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/15.jpg)
Slide 15 © PharmOut 2015
Fly Through
![Page 16: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/16.jpg)
Slide 16 © PharmOut 2015
Benefits of 3D and fly through
• Transforms CAD data into compelling imagery and movies to support conceptualisation of design
• Improve the factory design review process
• Multiple models or scenarios aids decision making
• Assists communication across boundaries (discipline, language and location)
Taking a real-time, virtual tour of your design provides:
• insight into your design intent while;
• demonstrating how it works
3D design avoids costly mistakes when designing multi floor facility
![Page 17: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/17.jpg)
Slide 17 © PharmOut 2015
• Measures to prevent cross-contamination and their effectiveness should be reviewed periodically according to set procedures.
Eudralex Volume 4, Chapter 5 - 5.22
Periodic Review
![Page 18: Using new 3D and fly through tools to visualise contamination...Using new 3D and fly through tools to visualise contamination risks Presented by Mairead Kennedy 4 July, 2016](https://reader033.vdocuments.mx/reader033/viewer/2022061003/60b173bddb04ef5ca76312eb/html5/thumbnails/18.jpg)
Slide 18 © PharmOut 2015
Thank you for your time.Questions?
Mairead Kennedy
Lead Consultant
www.pharmout.net